Conmed (CNMD)
NYSE:CNMD
Want to see CNMD full AI Analyst Report?
Total Valuation
Conmed has a market cap or net worth of $1.11B. The enterprise value is $1.90B.
Market Cap$1.11B
Enterprise Value$1.90B
Share Statistics
Conmed has 30,109,194 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,109,194
Owned by Insiders0.19%
Owned by Institutions31.72%
Financial Efficiency
Conmed’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.64%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)4.64%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee352.43K
Profits Per Employee12.07K
Employee Count3,900
Asset Turnover0.59
Inventory Turnover1.83
Valuation Ratios
The current PE Ratio of Conmed is 20.6. Conmed’s PEG ratio is -0.41.
PE Ratio20.6
PS Ratio0.92
PB Ratio1.22
Price to Fair Value1.22
Price to FCF8.35
Price to Operating Cash Flow7.91
PEG Ratio-0.41
Income Statement
In the last 12 months, Conmed had revenue of 1.37B and earned 47.05M in profits. Earnings per share was 1.52.
Revenue1.37B
Gross Profit725.38M
Operating Income141.13M
Pretax Income71.12M
Net Income47.05M
EBITDA193.47M
Earnings Per Share (EPS)1.52
Cash Flow
In the last 12 months, operating cash flow was 142.63M and capital expenditures -18.92M, giving a free cash flow of 123.71M billion.
Operating Cash Flow142.63M
Free Cash Flow123.71M
Free Cash Flow per Share4.11
Dividends & Yields
Conmed pays an annual dividend of $0.2, resulting in a dividend yield of 2.02%
Dividend Per Share$0.2
Dividend Yield2.02%
Payout Ratio13.27%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change-37.38%
50-Day Moving Average36.45
200-Day Moving Average42.08
Relative Strength Index (RSI)54.60
Average Volume (3m)368.83K
Important Dates
Conmed upcoming earnings date is Jul 29, 2026, After Close (Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateJul 29, 2026
Ex-Dividend Date―
Financial Position
Conmed as a current ratio of 2.14, with Debt / Equity ratio of 84.59%
Current Ratio2.14
Quick Ratio1.01
Debt to Market Cap0.66
Net Debt to EBITDA4.10
Interest Coverage Ratio4.54
Taxes
In the past 12 months, Conmed has paid 24.06M in taxes.
Income Tax24.06M
Effective Tax Rate0.34
Enterprise Valuation
Conmed EV to EBITDA ratio is 10.62, with an EV/FCF ratio of 13.61.
EV to Sales1.49
EV to EBITDA10.62
EV to Free Cash Flow13.61
EV to Operating Cash Flow12.03
Balance Sheet
Conmed has $35.03M in cash and marketable securities with $860.87M in debt, giving a net cash position of -$825.84M billion.
Cash & Marketable Securities$35.03M
Total Debt$860.87M
Net Cash-$825.84M
Net Cash Per Share-$27.43
Tangible Book Value Per Share-$11.47
Margins
Gross margin is 53.58%, with operating margin of 10.27%, and net profit margin of 3.42%.
Gross Margin53.58%
Operating Margin10.27%
Pretax Margin5.17%
Net Profit Margin3.42%
EBITDA Margin14.08%
EBIT Margin10.27%
Analyst Forecast
The average price target for Conmed is $39.39, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$39.39
Price Target Upside-11.18% Downside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast4.78%
EPS Growth Forecast-53.80%